Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Gayatri Projects Limited - Updates

2018-07-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GAYAPROJ 532767

0
Gayatri Projects stock jumps 5% on bagging Purvanchal Expressway road project

2018-07-10 moneycontrol
Gayatri Projects share price rallied more than 5 percent intraday on Tuesday after receiving Purvanchal Expressway road project.
GAYAPROJ 532767

0
Gayatri Highways to be listed on June 28

2018-06-27 thehindubusinessline
Gayatri Highways Ltd (the resulting company) has received approval from the BSE and NSE for listing of its equity shares. These shares will be traded with effect from Thursday, June 28, 2018.
GAYAPROJ 532767

0
Sadbhav Engineering looks to raise ₹1,500 crore through QIP this quarter

2018-06-21 livemint
Mumbai: Sadbhav Engineering Ltd, a Gujarat-based infrastructure company, is looking to raise ₹1,500 crore through a qualified institutional placement (QIP) in the current quarter, said two people close to the development.
GAYAPROJ SADBHAV 539126 532767 532710 MEP

7
Rs 1,111-cr Gayatri Projects bid for Purvanchal EWay cancelled

2018-06-20 moneycontrol
Gayatri Projects today said the UP government has reinvited bids for Purvanchal Expressway and cancelled the company's Rs 1,111-crore offer made earlier for a package under the scheme. Gayatri Projects was declared the lowest bidder for the VIth package of the project for a quoted price of Rs 1,111.03 crore.
ICICIBANK GAYAPROJ 532174 IBN 532767

0
Gayatri Projects Limited - Credit Rating

2018-06-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GAYAPROJ 532767

0
Gayatri Projects Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GAYAPROJ 532767

26
Market Live: Sensex mildly lower; all sectoral indices in the red except Auto

2018-06-01 moneycontrol
Market Update: The market continued to be mildly under pressure amid consolidation, but European stocks are strong in trade after Italy agreed to form a government.
BAJAJ-AUTO 539150 513262 500325 GAYAPROJ RELIANCE TTQQY 530239 PNCINFRA 532977 SUVEN TATACHEM 531795 505200 532343 RIGD HEROMOTOCO 500477 500570 TATAMOTORS EICHERMOT 500770 RLNIY ASHOKLEY ECQRY TVSMOTOR IBN ATULAUTO 532767 532843 MRZUY AKLD 532500 500182 ICICIBANK FORTIS MARUTI 532174 HRTQY AKLS SSWL TTM

29
Market Live: Sensex mildly lower, Midcaps underperform; HDFC Bank drags, Eicher Motors dips 4%

2018-06-01 moneycontrol
Allahabad High Court on Power NPAs: Allahabad High Court has stayed the Reserve Bank of India’s February 12 circular on resolution on non-performing assets (NPAs) for the assets in the power sector.
BAJAJ-AUTO 539150 513262 GAYAPROJ TTQQY 530239 PNCINFRA 532977 SUVEN TATACHEM 531795 505200 533106 OIL HDFCBANK HEROMOTOCO 500477 500570 TATAMOTORS EICHERMOT 500770 ASHOKLEY ECQRY IBN ATULAUTO 532767 532843 MRZUY AKLD 532500 500182 ICICIBANK FORTIS HDB MARUTI 532174 500180 HRTQY AKLS SSWL TTM

0
Gayatri Projects Limited - Updates

2018-06-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GAYAPROJ 532767

0
Gayatri Projects Limited - Investor Presentation

2018-05-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GAYAPROJ 532767

0
Gayatri Projects Limited - Investor Presentation

2018-05-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GAYAPROJ 532767

0
Will Gayatri Projects build on new orders?

2018-05-25 thehindubusinessline
Gayatri Projects has received a letter of award from the Ministry of Road Transport and Highways for part-construction of the six-lane elevated corridor (Hyderabad-Bhopalpatnam) in Telangana. This project — a joint venture between the company and OJSC SIBMOST — is worth ₹425 crore.
GAYAPROJ GAILY GAILF 532767

0
Gayatri Projects rises 2% on LoA for project worth Rs 425 cr

2018-05-25 moneycontrol
Shares of Gayatri Projects rose 2.3 percent intraday Friday as company received LoA from the Ministry of Road Transport and Highways.
GAYAPROJ 532767

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...